Key Insights

Highlights

Treatment Research

1 treatments under study, led by Cultivated Oral Mucosal Epithelial Sheet Transplantation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Cultivated Oral Mucosal Epithelial Sheet Transplantation1

Active Sponsors

  • Ministry of Health & Welfare, Korea1
  • Seoul National University Hospital1

Top Investigators

Related Conditions

  • Stevensjohnson Syndrome1
  • Ocular Cicatricial Pemphigoid1
  • Limbal Stem Cell Deficiency1

Activity Timeline